Facebook tracking pixel
S10.AI
ICD-10-CM · I82.403GeneralSystemic

Bilateral Deep Vein Thrombosis

Understanding Bilateral Deep Vein Thrombosis (Bilateral DVT): This resource provides information on Bilateral Venous Thrombosis diagnosis, covering clinical documentation, medical coding, and healthcare best practices. Learn about symptoms, risk factors, and treatment for Bilateral DVT, focusing on accurate medical terminology for optimized search and clinical documentation.

Also known as
Bilateral DVTBilateral Venous Thrombosis
Definition

Blood clots in deep veins of both legs, hindering blood return to the heart.

Clinical signs

Leg swelling, pain, warmth, redness, tenderness along the vein.

Common settings

Prolonged immobility (travel, surgery), inherited clotting disorders, cancer.

Related Codes

ICD-10 Code Families

Complete code families applicable to I82.403

I80.2
Deep vein thrombosis of lower extremity
I80.1
Deep vein thrombosis of lower extremity
I82.9
Other venous embolism and thrombosis
Code Comparison

When to use each related code

DescriptionWhen to use
Blood clots in both leg deep veins.Confirmed bilateral DVT. Use for acute or chronic cases. Include laterality.
Blood clot in one leg deep vein.Confirmed unilateral DVT. Specify affected leg (right/left). Use for acute or chronic.
Blood clot in arm deep vein.Confirmed upper extremity DVT. Specify affected arm (right/left). Consider cause (e.g., catheter).
Documentation

Best-practice checklist

  • Document Wells score and rationale.
  • Laterality: Specify right, left, or both legs.
  • Symptoms: Pain, swelling, redness, warmth.
  • Diagnostic tests: D-dimer, ultrasound findings.
  • Specify acute or chronic DVT.
Coding & Audit Risks

Common pitfalls to avoid

Laterality Specificity

Coding requires distinct left/right or bilateral DVT codes. Unspecified laterality leads to inaccurate coding and reimbursement.

DVT Acuity

Differentiating acute, chronic, or subacute DVT is crucial for proper code assignment and impacts clinical documentation improvement efforts.

Underlying Cause

Coding must reflect any underlying conditions (e.g., malignancy, trauma) contributing to the DVT for accurate severity reflection and quality reporting.

Mitigation

Best-practice tips

  • 01Accurate ICD-10 coding: I80.23, avoid unspecified codes
  • 02Detailed DVT laterality documentation (R/L leg)
  • 03Thorough HPI: onset, risk factors, symptoms
  • 04Medication reconciliation: anticoagulants, dosage
  • 05Timely follow-up care plans for optimal patient outcomes
Clinical Decision Support

Step-by-step checklist

  1. 1

    1. Verify bilateral leg symptoms (pain, swelling, redness)

  2. 2

    2. Confirm with duplex ultrasound of both legs

  3. 3

    3. Assess risk factors (Virchow's triad, recent surgery, immobility)

  4. 4

    4. Rule out other diagnoses mimicking DVT (cellulitis, muscle strain)

Documentation Template

Ready-to-paste narrative

Patient presents with symptoms suggestive of bilateral deep vein thrombosis (DVT), including bilateral leg pain, swelling, and tenderness.  The patient reports right leg pain as slightly more pronounced than the left.  On physical examination, there is noticeable edema in both lower extremities, with increased warmth and erythema observed bilaterally.  The patient denies any chest pain, shortness of breath, or hemoptysis, ruling out pulmonary embolism as an immediate concern.  Wells score was calculated and indicated a moderate probability of DVT.  Duplex ultrasound of both lower extremities was ordered to confirm the diagnosis.  The ultrasound revealed the presence of thrombi in the deep veins of both legs, confirming bilateral DVT.  Differential diagnoses considered included cellulitis, muscle strain, and Baker's cyst, but the ultrasound findings and clinical presentation are most consistent with bilateral venous thrombosis.  The patient's medical history includes [insert relevant medical history, e.g., recent surgery, prolonged immobility, family history of clotting disorders].  Current medications include [list current medications].  Assessment: Bilateral deep vein thrombosis.  Plan: Initiate anticoagulant therapy with [specify anticoagulant and dosage].  Patient education provided regarding the importance of medication adherence, signs and symptoms of pulmonary embolism, and potential complications of DVT.  Follow-up appointment scheduled in one week to monitor treatment response and adjust medication as needed.  Referral to hematology for further evaluation and long-term anticoagulation management is being considered.  ICD-10 code I80.22 (Bilateral deep vein thrombosis of lower extremities) assigned.
FAQs

Common questions and answers

What are the key differentiating factors in diagnosing bilateral deep vein thrombosis (Bilateral DVT) versus other causes of bilateral leg swelling?+

Bilateral leg swelling can be caused by various conditions, including heart failure, lymphedema, and cellulitis, making differentiating from bilateral deep vein thrombosis (Bilateral DVT) crucial. While all these conditions can present with edema, Bilateral DVT often presents with more acute pain, tenderness along the deep venous system, and potentially warmth and erythema. Heart failure typically presents with systemic signs such as shortness of breath and jugular venous distension. Lymphedema is usually chronic, often asymmetrical, and non-tender. Cellulitis presents with localized skin changes like redness, warmth, and tenderness. Differentiating between these requires careful clinical evaluation, including a thorough history and physical exam focusing on risk factors for DVT such as recent surgery, prolonged immobilization, or active malignancy. D-dimer can be a helpful adjunct, but it's non-specific. Compression ultrasonography (CUS) remains the gold standard for diagnosing Bilateral DVT. Consider implementing a standardized diagnostic approach for bilateral leg swelling to ensure prompt and accurate diagnosis. Explore how integrating clinical decision rules can improve diagnostic accuracy and patient outcomes.

How does the management of acute bilateral deep vein thrombosis (Bilateral DVT) differ from the management of unilateral DVT, considering potential complications like pulmonary embolism (PE)?+

While the initial management of acute bilateral deep vein thrombosis (Bilateral DVT) and unilateral DVT often involves anticoagulation, the extent of the thrombus burden in bilateral DVT warrants careful consideration of potential complications, especially pulmonary embolism (PE). Bilateral DVT inherently carries a higher risk of PE due to the larger clot burden. Anticoagulation remains the cornerstone of treatment, with options including direct oral anticoagulants (DOACs), low-molecular-weight heparin (LMWH), or fondaparinux followed by warfarin. In patients with extensive Bilateral DVT and high-risk features for PE, such as right heart strain or hemodynamic instability, thrombolysis may be considered. Furthermore, the presence of Bilateral DVT necessitates a more thorough investigation into underlying thrombophilia. Learn more about the latest guidelines for PE risk stratification and the role of advanced imaging in managing Bilateral DVT. Explore how a multidisciplinary approach involving hematologists and interventional radiologists can optimize patient care.

What are the recommended long-term anticoagulation strategies for patients with provoked versus unprovoked bilateral deep vein thrombosis (Bilateral Venous Thrombosis), and how do these strategies impact recurrence risk reduction?+

The duration of anticoagulation for bilateral deep vein thrombosis (Bilateral Venous Thrombosis) depends on whether the event was provoked (e.g., by surgery, trauma, or immobilization) or unprovoked. For provoked Bilateral Venous Thrombosis, a limited duration of anticoagulation (typically 3 months) is often sufficient, provided the provoking factor is resolved. However, for unprovoked Bilateral Venous Thrombosis, indefinite anticoagulation is often recommended, especially considering the higher risk of recurrence associated with bilateral involvement. The decision to extend anticoagulation beyond 3 months should be individualized based on the patient's bleeding risk, preferences, and the presence of persistent risk factors. Risk assessment tools, such as the DASH score or the HERDOO2 score, can help guide these decisions. Consider implementing strategies to optimize adherence to long-term anticoagulation, such as patient education and regular monitoring. Learn more about the latest evidence comparing different anticoagulants in terms of efficacy and safety in long-term recurrence risk reduction for Bilateral Venous Thrombosis.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.